"Out of an abundance of caution," read the letter from Cincinnati's Wm. S. Merrell Co. to 230,000 U.S. physicians, "we have determined that the sale of tripara-nol should be discontinued until all possible controversy is put to rest." Thus last week almost half a million patients learned that they could no longer hope to cut down the cholesterol circulating in their blood and perhaps reduce the danger of heart attacks simply by swallowing a daily 35^ triparanol capsule.
Triparanol (trade name: MER/29) was marketed two years ago with only a background...
To continue reading:
or
Log-In
